Emfo, LLC Avenue Therapeutics, Inc. Transaction History

Emfo, LLC

  • $108 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022
SELL
$0.22 - $0.56 $1,760 - $4,480
-8,000 Reduced 33.33%
16,000 $4,000
Q4 2021

Jan 27, 2022
SELL
$0.88 - $1.78 $17,239 - $34,870
-19,590 Reduced 44.94%
24,000 $22,000
Q2 2021

Jul 20, 2021
BUY
$2.41 - $7.11 $105,051 - $309,924
43,590 New
43,590 $109,000

About AVENUE THERAPEUTICS, INC.

ATXI Quotes by TradingView
  • Ticker ATXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,127,720
  • Market Cap $13.8M
  • Description
  • Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...
More about ATXI
Track This Portfolio

Track Emfo, LLC Portfolio

Follow Emfo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emfo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emfo, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email